Preparation of vaccine master cell lines using recombinant...

Chemistry: molecular biology and microbiology – Plant cell or cell line – per se ; composition thereof;... – Plant cell or cell line – per se – contains exogenous or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C800S298000, C800S295000, C800S288000, C435S468000

Reexamination Certificate

active

07553666

ABSTRACT:
The subject invention provides a plant cell culture for producing proteinaceous agents comprising a plant cell line stably transformed to express a transgene encoding a proteinaceous agent and a growth medium which supports the growth of said plant cell culture but which does not support the growth of Mycoplasmataceae and contains no materials of animal origin. The plant cell line is capable of being continuously passaged such that consistent transgene expression is maintained during passaging. The plant cell line is also capable of being cryopreserved such that consistent transgene expression is recovered upon recovery from cryopreservation.

REFERENCES:
patent: 5001060 (1991-03-01), Peacock et al.
patent: 5270200 (1993-12-01), Sun et al.
patent: 5273894 (1993-12-01), Strauch et al.
patent: 5276268 (1994-01-01), Strauch et al.
patent: 5290924 (1994-03-01), Last et al.
patent: 5310678 (1994-05-01), Bingham et al.
patent: 5384253 (1995-01-01), Krzyzek et al.
patent: 5484717 (1996-01-01), Zaccardi
patent: 5573932 (1996-11-01), Ellis et al.
patent: 5637489 (1997-06-01), Strauch et al.
patent: 5654184 (1997-08-01), Curtiss, III et al.
patent: 5679880 (1997-10-01), Curtiss, III et al.
patent: 5686079 (1997-11-01), Curtiss et al.
patent: 5773689 (1998-06-01), Thompson et al.
patent: 5773695 (1998-06-01), Thompson et al.
patent: 5824798 (1998-10-01), Tallberg et al.
patent: 5879903 (1999-03-01), Strauch et al.
patent: 5891665 (1999-04-01), Wilson
patent: 5914123 (1999-06-01), Arntzen et al.
patent: 6034298 (2000-03-01), Lam et al.
patent: 6136320 (2000-10-01), Arntzen et al.
patent: 6140075 (2000-10-01), Russell et al.
patent: 6184437 (2001-02-01), Sun et al.
patent: 6194560 (2001-02-01), Arntzen et al.
patent: 6239328 (2001-05-01), Thompson
patent: 6320101 (2001-11-01), Kaplan et al.
patent: 6395964 (2002-05-01), Arntzen et al.
patent: 2004/0166121 (2004-08-01), Arntzen et al.
patent: 2004/0268442 (2004-12-01), Miller et al.
patent: 2005/0048074 (2005-03-01), Cardineau et al.
patent: 2006/0222664 (2006-10-01), Miller et al.
patent: WO 91/09957 (1991-07-01), None
patent: WO 97/27207 (1997-07-01), None
patent: WO 97/48819 (1997-12-01), None
patent: WO 00/37609 (2000-06-01), None
Etienne et al. Biotechnological applications for the improvement of coffee (Coffea Arabica L.) (2002) In Vitro Cell. Dev. Biol.-Plant ; vol. 38, pp. 129-138.
Russell et al. Physical trauma and tungsten toxicity reduce the efficiency of biolistic transformation. (1992) Plant Phys. vol. 98, pp. 1050-1056.
GenBank Accession No. AF077761, Mar. 23, 1999, pp. 1-8.
GenBank Accession No. X00493, Apr. 18, 2005, pp. 1-16.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Preparation of vaccine master cell lines using recombinant... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Preparation of vaccine master cell lines using recombinant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of vaccine master cell lines using recombinant... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4146778

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.